Supernus Pharmaceuticals, Inc. (SUPN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$52.27
Day's range
$54.3

Supernus Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 8.80 M $454.73 M   0.70% 15.26%
MILLENNIUM MANAGEMENT LLC 05/15/2026 3.32 M $171.40 M   25.60% 5.75%
05/08/2026 3.24 M $167.41 M   100.00% 5.62%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 2.47 M $127.53 M   100.00% 4.28%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 2.31 M $119.24 M   -14.94% 4.00%
STATE STREET CORP 05/15/2026 2.29 M $118.27 M   3.10% 3.97%
MACQUARIE MANAGEMENT HOLDINGS, INC. 05/15/2026 2.04 M $105.30 M   -11.72% 3.53%
ARMISTICE CAPITAL, LLC 05/15/2026 1.90 M $97.97 M   -31.43% 3.29%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 1.71 M $88.14 M   -1.58% 2.96%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.62 M $83.93 M   10.23% 2.82%
CITADEL ADVISORS LLC 05/15/2026 1.49 M $77.20 M   229.71% 2.59%
LOOMIS SAYLES & CO L P 05/14/2026 1.43 M $73.70 M   -1.59% 2.47%
STEPHENS INVESTMENT MANAGEMENT GROUP LLC 04/28/2026 1.35 M $69.85 M   -3.92% 2.34%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 1.32 M $68.16 M   -41.78% 2.29%
GW&K INVESTMENT MANAGEMENT, LLC 05/13/2026 1.06 M $54.54 M   -2.36% 1.83%
SOFINNOVA INVESTMENTS, INC. 05/15/2026 954.31 K $49.33 M   72.54% 1.66%
MORGAN STANLEY 05/15/2026 913.89 K $47.24 M   -15.34% 1.59%
GOLDMAN SACHS GROUP INC 05/15/2026 856.49 K $44.27 M   29.71% 1.49%
BANK OF AMERICA CORP /DE/ 05/18/2026 714.23 K $36.92 M   37.15% 1.24%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 705.98 K $36.49 M   0.33% 1.22%
NORTHERN TRUST CORP 05/14/2026 699.46 K $36.15 M   4.33% 1.21%
ASHFORD CAPITAL MANAGEMENT INC 05/15/2026 645.38 K $33.36 M   5.36% 1.12%
FREESTONE GROVE PARTNERS LP 05/15/2026 641.32 K $33.15 M   226.67% 1.11%
D. E. SHAW & CO., INC. 05/15/2026 622.45 K $32.17 M   -12.08% 1.08%
ASSENAGON ASSET MANAGEMENT S.A. 04/20/2026 530.62 K $27.43 M   100.00% 0.92%
VICTORY CAPITAL MANAGEMENT INC 05/15/2026 502.41 K $25.97 M   -4.53% 0.87%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 498.20 K $25.75 M   59.76% 0.86%
RICE HALL JAMES & ASSOCIATES, LLC 05/15/2026 477.42 K $24.68 M   2.04% 0.83%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 450.76 K $22.27 M   -6.75% 0.78%
WOODLINE PARTNERS LP 05/15/2026 449.00 K $23.21 M   100.00% 0.78%
INVESCO LTD. 05/12/2026 412.68 K $21.33 M   4.28% 0.72%
SG AMERICAS SECURITIES, LLC 04/16/2026 377.21 K $19.50 M   2,846.98% 0.65%
SYSTEMATIC FINANCIAL MANAGEMENT LP 05/13/2026 376.08 K $19.44 M   23.62% 0.65%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 369.25 K $19.09 M   100.00% 0.64%
BANK OF NEW YORK MELLON CORP 05/05/2026 362.41 K $18.73 M   -2.26% 0.63%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 341.12 K $17.63 M   4.62% 0.59%
METLIFE INVESTMENT MANAGEMENT, LLC 05/14/2026 304.17 K $15.72 M   0.15% 0.53%
KRENSAVAGE ASSET MANAGEMENT, LLC 05/15/2026 280.68 K $14.51 M   -10.47% 0.49%
ABRDN PLC 04/29/2026 275.56 K $14.24 M   1.47% 0.48%
TWO SIGMA INVESTMENTS, LP 05/15/2026 271.23 K $14.02 M   124.78% 0.47%
JPMORGAN CHASE & CO 05/13/2026 250.74 K $12.37 M   -0.41% 0.43%
ROYCE & ASSOCIATES LP 05/12/2026 229.94 K $11.89 M   16.29% 0.40%
GLENMEDE TRUST CO NA 05/26/2026 219.10 K $11.33 M   -8.40% 0.38%
NUVEEN, LLC 04/30/2026 216.05 K $11.17 M   95.01% 0.37%
FMR LLC 05/15/2026 209.37 K $10.82 M   68.40% 0.36%
UBS GROUP AG 05/05/2026 209.12 K $10.81 M   385.80% 0.36%
PUBLIC SECTOR PENSION INVESTMENT BOARD 05/13/2026 205.16 K $10.60 M   3.40% 0.36%
ARISTOTLE CAPITAL BOSTON, LLC 05/15/2026 203.09 K $10.51 M   -13.39% 0.35%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/14/2026 202.12 K $10.45 M   -11.79% 0.35%
AMERIPRISE FINANCIAL INC 07/17/2026 173.91 K $8.99 M   -3.93% 0.31%

Supernus Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 486 institutional investors and hedge funds held shares of Supernus Pharmaceuticals Inc. The most heavily invested institutionals were:

Stephens Investment Management Group LLC: 1.49 M

abrdn plc: 453,206

Pictet Asset Management Holding SA: 432,478

Bank of New York Mellon Corp: 377,402

PRINCIPAL FINANCIAL GROUP INC: 348,461

Universal- Beteiligungs- und Servicegesellschaft mbH: 115,125

103.13% of Supernus Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 82.75 M shares in the last 24 months. This purchase volume represents approximately $4.48 B in transactions.